skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Corneal endothelial rejection after penetrating keratoplasty treated with intravenous and topic corticosteroid: one year follow up

Revista Brasileira de Oftalmologia, 2013-02, Vol.72 (1), p.42-45 [Peer Reviewed Journal]

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. ;ISSN: 1982-8551 ;DOI: 10.1590/S0034-72802013000100010

Digital Resources/Online E-Resources

Citations Cited by
  • Title:
    Corneal endothelial rejection after penetrating keratoplasty treated with intravenous and topic corticosteroid: one year follow up
  • Author: Abe, Ricardo Yuji ; Freire, Lívia Maria Dias ; Castro, Rosane Silvestre ; Lira, Rodrigo Pessoa Cavalcanti ; Arieta, Carlos Eduardo Leite
  • Subjects: Ceratoplastia penetrante ; Corticosteróides ; Fatores de risco ; Metilprednisolona ; OPHTHALMOLOGY ; Rejeição de enxerto ; Resultado de tratamento
  • Is Part Of: Revista Brasileira de Oftalmologia, 2013-02, Vol.72 (1), p.42-45
  • Description: OBJECTIVE: To analyze the recovery of visual acuity (VA) and graft survival after first episode of endothelial rejection in penetrating keratoplasty (PKP) treated with intravenous (IV) and topic corticosteroid. METHODS: Interventional, prospective, non-comparative case series study evolving 32 PKP patients in one year follow up, who presented first episode of corneal endothelial rejection. The patients were submitted to 500 mg IV injection of methylprednisolone in association with topical prednisolone. Main outcome measures included VA recovery and corneal edema regression. Second outcome included new rejections and graft failure. Multivariate analysis techniques were used to estimate rates of graft outcome events and the impact of risk factors. RESULTS: A total of 32 eyes from 32 patients (13 male and 19 female) were included in the study. The mean VA (in number of letters) before rejection was 48 (22 to 88 letters). Patients treated within 7 days or less of initial symptoms had better VA recovery, corneal edema regression and less graft failure (p<0.001). Patients with previous ocular surgery had worse VA recovery and more graft failure (p<0.047). CONCLUSION: The association between the other risk factors and the outcomes did not reach statistical significance in the multivariate model because of the small numbers of patients. Methylprednisolone in association with topical prednisolone is an alternative treatment for graft rejection. Our study showed that patients treated within 7 days of symptoms and no previous anterior segment surgery had better visual outcome and graft survival after treatment.
  • Publisher: Sociedade Brasileira de Oftalmologia
  • Language: Portuguese;English
  • Identifier: ISSN: 1982-8551
    DOI: 10.1590/S0034-72802013000100010
  • Source: DOAJ Directory of Open Access Journals

Searching Remote Databases, Please Wait